Americas

  1. The new, four-year Devices, Diagnostics, and Drugs to Address Women’s Needs Product Development Partnership (D3AWN PDP) is tapping into PATH’s deep PDP expertise to develop and introduce a portfolio of devices, diagnostics, and drugs to prevent or manage preeclampsia/eclampsia (PE/E) and PPH. The D3AWN PDP is advancing affordable, accessible, safe, and effective tools for sub-Saharan communities. Solutions include:Heat-stable FDT for PPH prevention: Sublingual oxytocin in heat-stable, fast dissolving tablet.Reusable, electricity-free infusion pump for the delivery of lifesaving nutrients, fluids, and medicines: RELI Delivery System.Uterine balloon tamponade for the management of PPH: Sinapi Ellavi Uterine Balloon Tamponade.Urinary dipstick test for improved diagnoses of PE/E: LifeAssay Diagnostics Test-it™ PrCr Urinalysis Dipstick Test
    Published: June 2019
    Type: Resource Page
  2. The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This brief presents findings synthesized across the eight PCE countries in 2018.
    Published: June 2019
    Type: Resource Page
  3. The Prospective Country Evaluation (PCE) is an independent evaluation of the Global Fund commissioned by the Global Fund’s Technical Evaluation Reference Group (TERG). The PCE evaluates how Global Fund policies and processes play out in country in real time and aims to provide high quality, actionable and timely information to national program implementers and Global Fund policymakers. The PCE is implemented by the Centro de Investigación Epidemiologica en Salud Sexual y Reproductiva (CIESAR) in collaboration with IHME and PATH in Guatemala.This report describes key findings from grant implementation from January–November of 2018.
    Published: March 2019
    Type: Resource Page
  4. PATH's work to improve the sexual and reproductive health of women (and men) stretches back to our inception in 1977, when we were founded to improve the quality of and accessibility to contraceptive products.
    Published: March 2019
    Type: Article
  5. The IDEA review is a global synthesis of existing evidence aimed at increasing the use of high-quality data to improve immunization coverage.The goal of the IDEA project is to identify, review, synthesize, and disseminate what works to improve the use of immunization data and why it works. In partnership with PAHO, the Health Systems Analytics team at PATH conducted a “realist” systematic review of existing research evidence to determine what are the most effective interventions to improve the use of data for immunization program and policy decision-making; and why and how these interventions produce the outcomes that they do.The IDEA review draws on nearly 550 documents including published literature, working papers, project evaluations and reports, which were distilled and prioritized by global immunization experts.
    Published: March 2019
    Type: Resource Page
  6. The IDEA review is a global synthesis of existing evidence aimed at increasing the use of high-quality data to improve immunization coverage.The goal of the IDEA project is to identify, review, synthesize, and disseminate what works to improve the use of immunization data and why it works. In partnership with PAHO, the Health Systems Analytics team at PATH conducted a “realist” systematic review of existing research evidence to determine what are the most effective interventions to improve the use of data for immunization program and policy decision-making; and why and how these interventions produce the outcomes that they do.The IDEA review draws on nearly 550 documents including published literature, working papers, project evaluations and reports, which were distilled and prioritized by global immunization experts.This précis highlights key takeaways from the full report.
    Published: March 2019
    Type: Resource Page
  7. The United States has a long history of leadership in global immunization. This educational fact sheet created by PATH and several advocacy partners highlights US government efforts in global immunization, including support for Gavi, the Vaccine Alliance; UNICEF; and the World Health Organization, as well as immunization activities carried out by the US Agency for International Development, US Department of Defense, and various agencies within the Department of Health and Human Services.
    Published: March 2019
    Type: Resource Page
  8. New report provides the immunization community with proven strategies for improving the quality and use of data.
    Published: February 2019
    Type: Article
  9. This one page fact sheet provides an overview of PATH’s Center of Excellence for Microarray Patch Technology: a four year initiative to mobilize efforts to accelerate the development of MAPs for critical vaccines, essential medicines, and diagnostics, and ensure that the MAP delivery technology platform can maximize its impact by meeting global public health needs.
    Published: February 2019
    Type: Resource Page
  10. An Excel model that estimates the number of women treated, the number of units of treatment equipment needed by type, and the associated start-up costs and cost of gas across five different scenarios. Click the link below to download the Excel file. SEE DISCLAIMER IN TOOL BEFORE USE
    Published: January 2019
    Type: Resource Page
Load more